Literature DB >> 7476297

Ethanol induces a paradoxical simultaneous increase in circulating concentrations of insulin-like growth factor binding protein-1 and insulin.

M Knip1, A C Ekman, M Ekman, J Leppäluoto, O Vakkuri.   

Abstract

The aim of this study was to examine the effect of acute alcohol intake on circulating concentrations of insulin, C-peptide, insulin-like growth factor (IGF) binding protein-1 (IGFBP-1), and plasma glucose levels. We measured these parameters for 12 hours after administration of 0, 0.5, or 1.0 g ethanol/kg body weight to nine healthy volunteers between 7:00 and 7:45 PM according to a randomized, double-blind, crossover design. Following a snack at 9:00 PM, plasma insulin (P < .05) and C-peptide (P < .01) concentrations were significantly increased at 10:00 PM in the 1.0-g group as compared with the control group. C-peptide to insulin molar ratios were significantly higher (P < .05) in both ethanol groups at 10:00 PM and 2:00 AM than in the control group. No differences were observed in plasma glucose levels between the three groups. Plasma IGFBP-1 levels showed a dose-dependent increase in the ethanol groups, and remained increased from 10:00 PM for 3 hours (P < .05 or less) at the lower dose and for 6 hours (P < .05 or less) at the higher dose. These observations indicate that ethanol-induced postprandial hyperinsulinemia is due to increased insulin secretion and that alcohol may increase hepatic insulin extraction. The lack of any effect on plasma glucose levels suggests that alcohol intake must be associated with decreased insulin sensitivity. Alcohol intake results in a paradoxical increase in peripheral concentrations of IGFBP-1 despite simultaneous hyperinsulinemia. This implies that ethanol has a direct stimulatory effect on hepatic IGFBP-1 synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476297     DOI: 10.1016/0026-0495(95)90042-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

Review 1.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence.

Authors:  S Röjdmark; K Brismar
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

3.  Effects of betaine on ethanol-stimulated secretion of IGF-I and IGFBP-1 in rat primary hepatocytes: involvement of p42/44 MAPK activation.

Authors:  Myeong Soo Lee; Myung-Sunny Kim; Soo Young Park; Chang-Won Kang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

4.  Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease.

Authors:  Heng-Hong Li; Kathryn Doiron; Andrew D Patterson; Frank J Gonzalez; Albert J Fornace
Journal:  J Transl Med       Date:  2013-10-23       Impact factor: 5.531

5.  A review on renal toxicity profile of common abusive drugs.

Authors:  Varun Parkash Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.